FULCRUM THERAPEUTICS
3,5700
07-октября-24 14:59:58
15 мин. задержка
Акции
-0,2500
-6,54%
Сегодняшний диапазон
3,5500 - 3,7800
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
09 апр 2021 12:15:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Appoints Judith A. Dunn, Ph.D. as President of Research and Development
24 мар 2021 08:29:00 Источник Nasdaq GlobeNewswire
-
18 мар 2021 10:30:00 Источник Nasdaq GlobeNewswire
-
04 мар 2021 06:01:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces CEO Transition
04 мар 2021 06:00:01 Источник Nasdaq GlobeNewswire
-
26 фев 2021 06:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Recognizes Rare Disease Day 2021
26 фев 2021 06:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate in Upcoming Investor Conferences
19 фев 2021 06:00:00 Источник Nasdaq GlobeNewswire
-
22 янв 2021 15:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock
19 янв 2021 21:34:02 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
19 янв 2021 15:01:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Promotion of Christopher Moxham, Ph.D., to Chief Scientific Officer
19 янв 2021 15:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate in the H.C. Wainwright BioConnect 2021 Conference
06 янв 2021 06:00:00 Источник Nasdaq GlobeNewswire